Sign in
Taking people in United StatesNo phase

Sampling gut bacteria with a capsule in people with irritable bowel syndrome

Collects gut bacteria with a swallowed capsule from healthy adults and adults with bowel disorders.

Key facts

Who runs it
Stanford University
Where
Redwood City, United StatesSee the site
Trial code
Registry title
Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
Status
Recruiting
People taking part
40 people, planned
Started
16 Nov 2023
Expected to end
1 Dec 2026
Type of study
Observational, 2 groups
Treatments tested
  • Microbiota Sampling
Record updated
22 January 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with irritable bowel syndrome (IBS) or other functional gut disorders, and healthy people. A swallowed capsule collects gut bacteria samples.

Age
18 to 70 years
Sex
All sexes
Disease stage
At least one symptom fitting SIBO (too many bacteria in the small bowel) and/or IBS, or a Rome IV diagnosis of a functional gut disorder. General health must be ASA class 1 or 2 (healthy or mild illness).
Earlier treatment
People cannot join if they are taking any medicine for a gut condition right now. People who have had stomach or esophagus surgery cannot join.
Biomarker or test result
Women who can become pregnant need a negative urine pregnancy test within 7 days of the screening visit.

Main reasons for not taking part

  • Past bowel blockage, stomach outlet blockage, diverticulitis or inflammatory bowel disease
  • Ileostomy or colostomy, stomach or esophagus cancer, achalasia or esophageal pouch
  • Current trouble or pain when swallowing
  • Pregnancy, planned pregnancy within 30 days of screening, or breast-feeding
  • Active drug or alcohol abuse, or an unstable medical or mental health condition

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Males or females 18 years of age or older and 70 years of age or younger at the time of the first Screening Visit
  • American Society of Anesthesiologists (ASA) Physical Status Classification System 1 or 2 (1-A normal healthy patient or 2-A patient with mild systemic disease)
  • For women of childbearing potential, negative urine pregnancy test within 7 days of Screening Visit. Willingness to use highly effective contraception during the entire study period (e.g.: implants, injectables, oral contraceptives, intra-uterine device or declared abstinence)
  • Subject is fluent in English and understands the study protocol and informed consent and is willing and able to comply with study requirements and sign the informed consent form
  • Positive for at least one clinical symptoms consistent with SIBO and or IBS and or a Rome Diagnosis of functional GI disorder (Rome IV criteria)

Who cannot take part

  • History of any of the following:; Prior gastric or esophageal surgery, including lap banding or bariatric surgery; Bowel obstruction; Gastric outlet obstruction; Diverticulitis; Inflammatory bowel disease; Ileostomy or colostomy; Gastric or esophageal cancer; Achalasia; Esophageal diverticulum
  • Active medication use for any gastrointestinal conditions
  • Any form of active substance abuse or dependence (including drug or alcohol abuse), unstable medical or psychiatric disorder, or any chronic condition susceptible, in the opinion of the investigator, to interfere with the conduct of the study
  • Active Dysphagia or Odynophagia
  • Pregnancy or planned pregnancy within 30 days from Screening Visit, or breast-feeding

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Where in United States

  • Stanford Digestive Health ClinicRedwood City, United StatesContact: Sean Spencer, MD/PhDTaking people

About the trial

What the trial wants to find out

We will sample intestinal microbiota using a microbiome sampling capsule in Healthy, Irritable Bowel Syndrome (IBS), and Functional Gastrointestinal Disease.

The 2 groups in the trial

  • Healthy patients

    Treatment: Microbiota Sampling

  • IBS/Functional GI diasease

    Patients with IBS or Functional GI disease (bloating, diarrhea, constipation)

    Treatment: Microbiota Sampling

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Capsule Microbiota Sampling in IBS/Functional Gastrointestinal Disease
Plain-language title
Sampling gut bacteria with a capsule in people with irritable bowel syndromeGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT06215222, who can take part
Record updated
22 January 2024